AZ Pediatría
Article not rated

Vol. 24 - Num. 96

Clinical Reviews

Botulism in an infant

Nuria Serrano Crespoa, Marta Romero Fernándezb, Laura Gómez-Pantoja Gonzálezc, Patricia López Carballoc, M.ª Isabel López Gonzálezc, Demetrio López Paciosd

aMedicina Familiar y Comunitaria. CS Bembibre. Bembibre. León. España.
bAnálisis Clínicos. Real Fundación Hospital de la Reina. Ponferrada. León. España.
cEnfermera. Servicio de Pediatría. Hospital El Bierzo. Ponferrada. León. España.
dServicio de Pediatría. Real Fundación Hospital de la Reina. Ponferrada. León. España.

Correspondence: N Serrano . E-mail:

Reference of this article: Serrano Crespo N, Romero Fernández M, Gómez-Pantoja González L, López Carballo P, López González MI, López Pacios D. Botulism in an infant . Rev Pediatr Aten Primaria. 2022;24:401-4.

Published in Internet: 29-11-2022 - Visits: 5447


Infant botulism is a disease caused by potent protein neurotoxins produced by Clostridium botulinum, which interfere with the presynaptic release of acetylcholine at the neuromuscular junction, being common in infants and causing abdominal pain, vomiting, acute paralysis including respiratory paralysis, diplopia and blurred vision. The treatment with a specific immunoglobulin prevents the evolution of the clinical picture that can cause death. We present a case of botulism in an infant in a medical center.


Clostridium botulinum Botulism Infant Specific human immunoglobulin


This article has no comments yet.